Roivant Sciences Ltd (ROIV)

May 16, 2025

Don't Ignore The Insider Selling In Roivant Sciences - simplywall.st

May 16, 2025

May 14, 2025

Transcript : Immunovant, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-14-2025 04 - marketscreener.com

May 14, 2025

May 14, 2025

Roivant Sciences at BofA Securities: Strategic Shifts and Litigation Focus By Investing.com - Investing.com India

May 14, 2025

May 14, 2025

Transcript : Roivant Sciences Ltd. Presents at BofA Securities 2025 Healthcare Conference, May-14-2025 04 - marketscreener.com

May 14, 2025

May 14, 2025

Roivant Sciences at BofA Securities: Strategic Shifts and Litigation Focus - Investing.com Australia

May 14, 2025

May 14, 2025

How To Trade (ROIV) - news.stocktradersdaily.com

May 14, 2025

May 04, 2025

(ROIV) On The My Stocks Page - news.stocktradersdaily.com

May 04, 2025

May 02, 2025

Roivant Sciences Ltd. (ROIV): Among David Einhorn’s Stock Picks with Huge Upside Potential - Yahoo Finance

May 02, 2025

Apr 29, 2025

Roivant Sciences Ltd. (ROIV): Among Billionaire Andreas Halvorsen’s Stock Picks With Huge Upside Potential - Insider Monkey

Apr 29, 2025

Apr 24, 2025

Roivant Reports Financial Results for the Second Quarter Ended September 30, 2024, and Provides Business Update - ADVFN

Apr 24, 2025

Apr 23, 2025

Roivant Sciences: Primed For Growth With A De-Risked Pipeline (NASDAQ:ROIV) - Seeking Alpha

Apr 23, 2025

Apr 22, 2025

Roivant sciences president Eric Venker sells $1.02 million in stock By Investing.com - Investing.com India

Apr 22, 2025

Apr 22, 2025

Roivant sciences president Eric Venker sells $1.02 million in stock - Investing.com

Apr 22, 2025

Apr 22, 2025

Roivant Sciences stock holds $18 target, management shuffle - Investing.com Australia

Apr 22, 2025

Apr 22, 2025

Roivant Sciences stock holds $18 target, management shuffle By Investing.com - Investing.com South Africa

Apr 22, 2025

Apr 21, 2025

Cantor Fitzgerald maintains overweight on Roivant Sciences stock - Investing.com Australia

Apr 21, 2025

Apr 21, 2025

Immunovant makes leadership changes - MSN

Apr 21, 2025

Apr 21, 2025

Roivant Tightens Leadership Grip On Immunovant, Narrows Near-Term IMVT-1402 Focus - insights.citeline.com

Apr 21, 2025

Apr 21, 2025

Cantor Fitzgerald maintains overweight on Roivant Sciences stock By Investing.com - Investing.com South Africa

Apr 21, 2025

Apr 21, 2025

Immunovant, Inc. Announces the Expanded Development of Imvt-1402 into Two New Indications, Sjd and Cle - marketscreener.com

Apr 21, 2025

Apr 21, 2025

Immunovant Announces Next Phase Of Growth With Roivant Including Changes To Its Leadership Team And Additional Indications - marketscreener.com

Apr 21, 2025

Apr 18, 2025

When (ROIV) Moves Investors should Listen - news.stocktradersdaily.com

Apr 18, 2025

Apr 11, 2025

Is Roivant Sciences Ltd. (ROIV) the Top Healthcare Stock to Buy According to Billionaire David Einhorn? - Yahoo Finance

Apr 11, 2025

Apr 10, 2025

Roivant Sciences Ltd. (ROIV): Among the Best Low Priced Growth Stocks to Invest In - Insider Monkey

Apr 10, 2025

Apr 09, 2025

ROIV Factor-Based Stock Analysis - Nasdaq

Apr 09, 2025

Apr 07, 2025

Immunovant, Roivant slip after trial data for autoimmune disorder therapy - MSN

Apr 07, 2025

Apr 02, 2025

Knott David M Jr Decreases Stock Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Apr 02, 2025

Apr 02, 2025

KLP Kapitalforvaltning AS Invests $918,000 in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Apr 02, 2025

Mar 31, 2025

ROIV stock touches 52-week low at $9.96 amid market fluctuations By Investing.com - Investing.com South Africa

Mar 31, 2025

Mar 31, 2025

ROIV stock touches 52-week low at $9.96 amid market fluctuations - Investing.com Australia

Mar 31, 2025

Mar 29, 2025

Is Roivant Sciences (ROIV) the Best Mid Cap Biotech Stock to Buy? - Insider Monkey

Mar 29, 2025

Mar 29, 2025

Loomis Sayles & Co. L P Has $43.43 Million Stock Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Mar 29, 2025

Mar 28, 2025

Insider Selling: Roivant Sciences Ltd. (NASDAQ:ROIV) COO Sells 315,522 Shares of Stock - MarketBeat

Mar 28, 2025

Mar 25, 2025

Is Roivant Sciences Ltd. (NASDAQ:ROIV) One of The Best Stocks to Buy According to Billionaire David Einhorn? - Insider Monkey

Mar 25, 2025

Mar 25, 2025

Roivant Sciences president Eric Venker sells shares worth $8.19 million By Investing.com - Investing.com UK

Mar 25, 2025

Mar 24, 2025

Roivant Sciences president Eric Venker sells shares worth $8.19 million - Investing.com

Mar 24, 2025

Mar 23, 2025

(ROIV) Trading Advice - news.stocktradersdaily.com

Mar 23, 2025

Mar 20, 2025

Roivant Sciences finalizes consulting agreement with former officer - Investing.com India

Mar 20, 2025

Mar 19, 2025

Roivant Phase III Batoclimab Trial Is Positive, But No Filing Planned - insights.citeline.com

Mar 19, 2025

Mar 19, 2025

Roivant Sciences Says Phase 3 MG Study Meets Primary Endpoint -March 19, 2025 at 08:24 am EDT - Marketscreener.com

Mar 19, 2025

Mar 19, 2025

Roivant Sciences Announces Positive Results for Batoclimab Studies - TipRanks

Mar 19, 2025

Mar 18, 2025

Critical Clinical Data Coming: Roivant's Dual Breakthrough Results in MG and CIDP Studies - Stock Titan

Mar 18, 2025

Mar 12, 2025

(ROIV) Trading Signals - Stock Traders Daily

Mar 12, 2025